Operating Lease, Right-of-Use Asset of Whitehawk Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Whitehawk Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Whitehawk Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Whitehawk Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$886,000 -100% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $0 -$982,000 -100% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $0 -$1,077,000 -100% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $787,000 -$382,000 -33% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $886,000 -$374,000 -30% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $982,000 -$367,000 -27% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $1,077,000 -$360,000 -25% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $1,169,000 -$353,000 -23% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $1,260,000 -$313,000 -20% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $1,349,000 -$304,000 -18% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $1,437,000 +$919,000 +177% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $1,522,000 +$965,000 +173% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $1,573,000 +$976,000 +163% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $1,653,000 +$1,643,548 +17388% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $518,000 +$480,840 +1294% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $557,000 +$438,000 +368% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $597,000 +$507,239 +565% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $9,452 -$105,262 -92% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $37,160 -$101,660 -73% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $119,000 -$43,124 -27% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $89,761 -$334,990 -79% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $114,714 -$357,421 -76% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $138,820 -$379,156 -73% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $162,124 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $424,751 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $472,135 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $517,976 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.